Product Information

ZAFIRLUKAST 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6436 per EA under NDC 59651029260. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Nov 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZAFIRLUKAST 20 MG TABLET

Zafirlukast
$0.6436per EA

Strength

20 mg/1

NDC

59651029260

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

Generic (ANDA)

FDA Application

ANDA213163

FDA Approved

11/27/2023

TE Code

AB

On Market Since

11/27/2023

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for ZAFIRLUKAST 20 MG TABLET has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 25.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6436 per EA
All-time high$0.8628 (Mar 13, 2024)
All-time low$0.4512 (Nov 20, 2024)
52-week high$0.6852
52-week low$0.6359
Median price$0.6654
Average price$0.6595
Largest weekly change-33.6% (Nov 20, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

+1.2%

1M

+1.2%

3M

-3.3%

6M

-1.3%

1Y

-4.5%

3Y

N/A

5Y

N/A

All

-25.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZAFIRLUKAST 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6436 per EA (NDC 59651029260), effective Aug 19, 2026.

How has the price of ZAFIRLUKAST 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZAFIRLUKAST 20 MG TABLET has declined 25.4%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 20 MG TABLET?

Since Mar 13, 2024, the NADAC for ZAFIRLUKAST 20 MG TABLET has ranged from a low of $0.4512 (Nov 20, 2024) to a high of $0.8628 (Mar 13, 2024), with a median of $0.6654 per EA.

Are there cheaper alternatives to ZAFIRLUKAST 20 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZAFIRLUKAST 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZAFIRLUKAST 20 MG TABLET?

ZAFIRLUKAST 20 MG TABLET (NDC 59651029260) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.